Literature DB >> 11929805

Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs.

Jie-Guang Chen1, Susan Band Horwitz.   

Abstract

Although microtubule interacting agents inhibit spindle dynamics, thereby leading to a block in mitosis, we report that low concentrations of these drugs result in differential mitotic effects. Microtubule-stabilizing agents including Taxol, epothilone B, and discodermolide produce aneuploid populations of A549 cells in the absence of a mitotic block. Such aneuploid populations are diminished in an epothilone B-resistant cell line. In contrast, microtubule-destabilizing agents like colchicine, nocodazole, and vinblastine are unable to initiate aneuploidy. The aneuploid cells result from aberrant mitosis as multipolar spindles are induced by the stabilizing drugs, but not by destabilizing agents. The results suggest that the mechanism underlying aberrant mitosis may not be the same as that responsible for mitotic block, and that the former determines the sensitivity of cells to Taxol-like drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929805

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  67 in total

Review 1.  Mechanisms of Taxol resistance related to microtubules.

Authors:  George A Orr; Pascal Verdier-Pinard; Hayley McDaid; Susan Band Horwitz
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

2.  Potentiation of taxol efficacy and by discodermolide in ovarian carcinoma xenograft-bearing mice.

Authors:  Gloria S Huang; Lluis Lopez-Barcons; B Scott Freeze; Amos B Smith; Gary L Goldberg; Susan Band Horwitz; Hayley M McDaid
Journal:  Clin Cancer Res       Date:  2006-01-01       Impact factor: 12.531

Review 3.  Spindle checkpoint function and cellular sensitivity to antimitotic drugs.

Authors:  Hiroshi Y Yamada; Gary J Gorbsky
Journal:  Mol Cancer Ther       Date:  2006-12       Impact factor: 6.261

4.  Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience.

Authors:  Aina He; Weixiang Qi; Yujing Huang; Yuanjue Sun; Zan Shen; Hui Zhao; Yumei Yang; Yang Yao
Journal:  Int J Clin Oncol       Date:  2012-04-26       Impact factor: 3.402

Review 5.  Drug development from marine natural products.

Authors:  Tadeusz F Molinski; Doralyn S Dalisay; Sarah L Lievens; Jonel P Saludes
Journal:  Nat Rev Drug Discov       Date:  2008-12-19       Impact factor: 84.694

6.  Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells.

Authors:  Aniek Janssen; Geert J P L Kops; René H Medema
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-23       Impact factor: 11.205

7.  Low-dose laulimalide represents a novel molecular probe for investigating microtubule organization.

Authors:  Melissa J Bennett; Gordon K Chan; J B Rattner; David C Schriemer
Journal:  Cell Cycle       Date:  2012-08-08       Impact factor: 4.534

Review 8.  Mitotic catastrophe: a mechanism for avoiding genomic instability.

Authors:  Ilio Vitale; Lorenzo Galluzzi; Maria Castedo; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2011-04-29       Impact factor: 94.444

9.  Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes.

Authors:  Mijung Kwon; Susana A Godinho; Namrata S Chandhok; Neil J Ganem; Ammar Azioune; Manuel Thery; David Pellman
Journal:  Genes Dev       Date:  2008-07-28       Impact factor: 11.361

10.  An intermittent live cell imaging screen for siRNA enhancers and suppressors of a kinesin-5 inhibitor.

Authors:  Melody Tsui; Tiao Xie; James D Orth; Anne E Carpenter; Stewart Rudnicki; Suejong Kim; Caroline E Shamu; Timothy J Mitchison
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.